OBJECTIVE: To assess the effect of vitamin D supplementation on enhancement of embryos implantation rates in intracytoplasmic sperm injection procedures. STUDY DESIGN: A randomized double-blinded controlled trial. SETTING: Assisted Reproduction Unit of Obstetrics and Gynecology Department, Faculty of Medicine, South Valley University, Egypt. DURATION: From December 1 st 2017 to the end of October 2018. SUBJECTS and METHDS: Eighty infertile couples that underwent ICSI procedure were entrapped in this study. Patients were divided into two groups; Group I (Vitamin D group) = 40 patients (received vitamin D supplementation in the form of Vidrop oral drops 600 IU/day starting after ovum pickup) and Group II (placebo group) = 40 patients (received a placebo "normal saline oral drop"). RESULTS: There was a significantly increased embryo implantation rates (53.2% in vitamin D group versus 46.7% in placebo group), there was a mild statistically significant difference in the clinical pregnancy rates (45.9% in vitamin D group versus 39.4% in placebo group) with p-value < 0.05 and there was an improvement in ongoing pregnancy rate as there was a mild statistically significant difference in first trimester miscarriage rates (12.5% in vitamin D group versus 17.5% in placebo group) with p value < 0.05 CONCLUSIONS: Vitamin D supplementation could improve embryos implantation rates and rate of ongoing pregnancy by decline in the first trimester miscarriage rate.
Introduction
Infertility is considered the most common disease of reproductive-age, affecting 15% to 25% of all couples who try to have a baby in western countries [1] . Assisted reproductive technology (ART) has emerged as the most effective treatment modality to overcome infertility problem and currently is responsible for the birth of more than 50,000 babies in the United States alone [2] and about 140,000 babies in Europe yearly [3] . So all the time there are many trials of studies to identify the potentially modifiable predictors of the successfully treatment method, including patient diet regimen and her lifestyle.
Vitamin D has a common name "sunshine hormone", that is a fat soluble hormone which has an integral part in calcium & phosphorous homeostasis and has a role in maintaining healthy bone and teeth, also it is involved in providing the protection against a large number of diseases like cancer, multiple sclerosis, diabetes, obesity, cardiovascular diseases and many other diseases; also it is thought to have a role in infertility treatment [4] .
Vitamin D deficiency had been advocated as a possible reason of infertility in many previous studies in literature for the past several years [5] . In rodent models, vitamin D deficiency declines fertility rates in females as a result of hypoplastic uterus, impaired follicular growth, and chronic anovulation [6] . Vitamin D biological actions are mediated through the receptors of vitamin D which has been detected in intestines, parathyroid glands, the skeleton and reproductive organs involving the ovary, uterus, placenta, and pituitary gland [7] .
In many studies, vitamin D deficiency was highly prevalent in infertile women with polycystic ovary syndrome (PCOS) [8] . It has been postulated that vitamin D may play an important role in the process of embryos implantation where vitamin D enzymes and vitamin D receptors have been detected in the endometrial tissues [9] . Vitamin D deficiency had been linked to poor and abnormal placentation that lead to hypertensive disorders of pregnancy and intrauterine growth restriction of the fetus [10] . Vitamin D can modulate the inflammatory and proliferation process in endometriotic cells, and decrease in Vitamin D levels could be associated with development endometriosis, so vitamin D supplementation could be a novel therapeutic strategy for managing endometriosis [11] . 
Aim of Work

Methodology
Patients were divided into two groups; Group I (Vitamin D group) = 40 patients (received vitamin D supplementation in the form of Vidrop oral drops 600 IU/day "6 oral drops". The vitamin D supplementation had started after the day of oocytes retrieval) and Group II (placebo group) = 40 patients (received a placebo "normal saline oral drop") also placebo administration had started after day of oocytes retrieval. Closed bags prepared and labeled as bags A (Vitamin D group) contained Vitamin D, and bags B (placebo group). Providers and patients had been blinded to the contents of the bags till the study was ended. ICSI procedure was done for all cases and only 1 -2 embryos (day 3 and day 5) had been allowed to be transferred to each women according to the degree of embryos qualities, the remained good quality embryos were frozen for subsequent transfer in non-stimulated cycles in future with couples permissions.
Hormonal support for luteal phase started in day of ova pick up till pregnancy test time (2 weeks post embryos transfer), for positive pregnancy test cases, luteal support continued for the next 3 months. Positive pregnancy test cases had to continue vitamin D supplementation up to the end first trimester of pregnancy. Pregnancy was evaluated by transvaginal ultrasound (SAMSUNG, Korea), in first trimester for confirmation of presence and number of gestational sacs, viability and exclude missed and ectopic pregnancies.
Assignment and Masking
Women were randomized in a 1:1 ratio according to a computer-generated randomization list generated by a research nurse not involved in their clinical management. The hospital pharmacy packaged Vitamin D and identical placebo 
Statistical Analysis
Analysis and statistical presentation of this study were conducted, using the mean, standard error, unpaired student t-test, and chi-square tests using the Statistical Program for Social Sciences (SPSS Inc., Version 21.0, Chicago, IL, USA).
A two sided P < 0.05 was considered to be statistically significant.
Results
There was no statistically significant difference between group I and group II in patient baseline characteristics, duration and doses of controlled ovarian stimulation, retrieved oocytes number, fertilization rate, qualities of embryo or endometrial thickness with p value > 0.05 (Table 1 & Table 2 ).
There was a significantly increased the embryo implantation rates (53.2% in vitamin D group versus 46.7% in placebo group), there was a mild statistically significant difference in the clinical pregnancy rates between the two groups (45.9% in vitamin D group versus 39.4% in placebo group) with p-value < 0.05
and there was an improvement in ongoing pregnancy rate as there was a mild statistically significant difference in first trimester miscarriage rates (12.5% in vitamin D group versus 17.5% in placebo group) with p value < 0.05 ( Figure 1 ). 
Discussion
Several In the current study showed no statistically significant differences between vitamin D group and placebo group as regard to women age, body mass index, AMH, causes and duration of infertility with p value > 0.05 (Table 1) . Also in this study there were no significant differences between both groups in the gonadotrophins drugs doses, duration of gonadotrophins stimulation, number of retrieved oocytes, and endometrial thickness at time of ovum pickup, fertilization rate or embryo quality ( Table 2) . [19] in California (in 2012) in 1192 of reproductive age women, it had been observed that most of the infertile women had low serum vitamin D levels with 68.6% cases had levels < 32 ng/ml and 22.2% had levels < 20 ng/ml, the study observed that increased BMI of patients, Asian and blacks races were at the highest risk of vitamin D deficiency, especially Asian women.
Gebriel et al. [20] had suggested that females with high levels of 25-hydroxy-vitamin D were significantly higher than those with low levels of vitamin D to achieve clinical pregnancy with ICSI procedure. Rainer et al. [21] (in Oklahoma) retrospectively had evaluated 53 patients had PCOS and had found the deficiency of vitamin D was highly prevalent in these cases, but they had found no positive correlation with Vitamin D levels and the time.
Ozkan et al. [22] study had measured the levels of vitamin D both in the patients serum and in follicular fluid during oocytes retrieval and found the fol- 
Conclusions
Vitamin D supplementation pre-embryo transfer had; 1) A significant enhanced embryos implantation rate;
2) A significant improvement in ongoing pregnancy by decline rate of first trimester miscarriage.
